Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

31.07.2017

5 Am J Pathol
1 Am J Surg
1 Ann Surg
3 Ann Surg Oncol
14 Anticancer Res
3 BMC Cancer
1 Breast Cancer
4 Breast Cancer (Dove Med Press)
3 Breast Cancer Res
12 Breast Cancer Res Treat
3 Breast J
1 Cancer Res
4 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Cancer
1 Eur J Surg Oncol
1 Exp Cell Res
1 Gene
1 Int J Oncol
3 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 Lancet Oncol
1 Mod Pathol
1 NPJ Breast Cancer
2 Oncol Rep
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology
1 Radiother Oncol



    Am J Pathol

  1. RUSSNES HG, Lingjaerde OC, Borresen-Dale AL, Caldas C, et al
    Breast cancer molecular stratification- from intrinsic subtypes to integrative clusters.
    Am J Pathol. 2017 Jul 18. pii: S0002-9440(17)30134.
    >> Share

  2. ROSENBAUM JN, Weisman P
    The Evolving Role of Companion Diagnostics for Breast Cancer in an Era of Next-Generation Omics.
    Am J Pathol. 2017 Jul 18. pii: S0002-9440(17)30069.
    >> Share

  3. MAROTTI JD, de Abreu FB, Wells WA, Tsongalis GJ, et al
    Triple Negative Breast Cancer: Next-Generation Sequencing for Target Identification.
    Am J Pathol. 2017 Jul 19. pii: S0002-9440(17)30291.
    >> Share

  4. DAVALOS V, Martinez-Cardus A, Esteller M
    The Epigenomic Revolution in Breast Cancer: From Single-Gene to Genome-Wide Next-Generation Approaches.
    Am J Pathol. 2017 Jul 19. pii: S0002-9440(17)30582.
    >> Share

  5. MARDAMSHINA M, Geiger T
    Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research.
    Am J Pathol. 2017 Jul 20. pii: S0002-9440(17)30035.
    >> Share


    Am J Surg

  6. CHIU AS, Thomas P, Killelea BK, Horowitz N, et al
    Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB).
    Am J Surg. 2017 Jul 18. pii: S0002-9610(16)30870.
    >> Share


    Ann Surg

  7. POODT IGM, Spronk PER, Vugts G, van Dalen T, et al
    Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002440.
    >> Share


    Ann Surg Oncol

  8. WAHNER HENDRICKSON AE, Bakkum-Gamez JN, J Couch F, Ghosh K, et al
    Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
    Ann Surg Oncol. 2017 Jul 20. doi: 10.1245/s10434-017-5999.
    >> Share

  9. CHANG YC, Chen CK, Chen MJ, Lin JC, et al
    Expression of 3beta-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.
    Ann Surg Oncol. 2017 Jul 25. doi: 10.1245/s10434-017-6000.
    >> Share

  10. SHUMWAY DA, Griffith KA, Sabel MS, Jones RD, et al
    Surgeon and Radiation Oncologist Views on Omission of Adjuvant Radiotherapy for Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2017 Jul 26. doi: 10.1245/s10434-017-6013.
    >> Share


    Anticancer Res

  11. WANG L, Qi Y, Xiong Y, Peng Z, et al
    Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
    Anticancer Res. 2017;37:4353-4360.
    >> Share

  12. RIAZ SK, Ye L, Sahar NE, Aman D, et al
    Transcriptional Profiling of Sonic Hedgehog in a Prospective Cohort of Breast Cancer in a Pakistani Population.
    Anticancer Res. 2017;37:4449-4454.
    >> Share

  13. LI Z, Peng Z, Gu S, Zheng J, et al
    Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Anticancer Res. 2017;37:4455-4468.
    >> Share

  14. LIANG G, Liu Z, Tan L, Su AN, et al
    HIF1alpha-associated circDENND4C Promotes Proliferation of Breast Cancer Cells in Hypoxic Environment.
    Anticancer Res. 2017;37:4337-4343.
    >> Share

  15. LIU Z, Liang G, Tan L, Su AN, et al
    High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Anticancer Res. 2017;37:4329-4335.
    >> Share

  16. UHERCIK M, Sanders AJ, Owen S, Davies EL, et al
    Clinical Significance of PD1 and PDL1 in Human Breast Cancer.
    Anticancer Res. 2017;37:4249-4254.
    >> Share

  17. KLAPKO O, Ghoulam E, Jakate S, Eswaran S, et al
    Anastrozole-induced Autoimmune Hepatitis: A Rare Complication of Breast Cancer Therapy.
    Anticancer Res. 2017;37:4173-4176.
    >> Share

  18. CARBONNELLE D, Luu TH, Chaillou C, Huvelin JM, et al
    LXR Activation Down-regulates Lipid Raft Markers FLOT2 and DHHC5 in MCF-7 Breast Cancer Cells.
    Anticancer Res. 2017;37:4067-4073.
    >> Share

  19. MALIK MFA, Riaz SK, Waqar SH, Haq F, et al
    Role of Plexin B1 in a Breast Cancer Cohort of Pakistani Patients and its Contribution Towards Cancer Metastasis as Indicated by an In Vitro Model.
    Anticancer Res. 2017;37:4483-4488.
    >> Share

  20. ZENG Y, Li Q, Qin T, Li S, et al
    Impact of a 21-Gene Recurrence Score Test on the Choice of Adjuvant Chemotherapy for Hormone Receptor-positive Early-stage Breast Cancer: A Prospective Study.
    Anticancer Res. 2017;37:4539-4547.
    >> Share

  21. QIN T, Zeng YD, Lu Q, Zhang X, et al
    Nomogram Model of LNR Predicts Survival in Premenopausal Patients with Node-positive Luminal Breast Cancer.
    Anticancer Res. 2017;37:4575-4586.
    >> Share

  22. LANG Z, Wu Y, Li C, Li X, et al
    Multifocal and Multicentric Breast Carcinoma: A Significantly More Aggressive Tumor than Unifocal Breast Cancer.
    Anticancer Res. 2017;37:4593-4598.
    >> Share

  23. ZHOU B, Xu L, Ye J, Xin L, et al
    The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
    Anticancer Res. 2017;37:4615-4621.
    >> Share

  24. YE J, Wang W, Xin L, Owen S, et al
    The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
    Anticancer Res. 2017;37:4549-4556.
    >> Share


    BMC Cancer

  25. MAATTA KM, Nurminen R, Kankuri-Tammilehto M, Kallioniemi A, et al
    Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    BMC Cancer. 2017;17:496.
    >> Share

  26. LUDOVINI V, Antognelli C, Rulli A, Foglietta J, et al
    Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.
    BMC Cancer. 2017;17:502.
    >> Share

  27. DECKER T, Overkamp F, Rosel S, Nusch A, et al
    A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO).
    BMC Cancer. 2017;17:499.
    >> Share


    Breast Cancer

  28. NAKAMURA R, Yamamoto N, Miyaki T, Itami M, et al
    Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
    Breast Cancer. 2017 Jul 22. doi: 10.1007/s12282-017-0795.
    >> Share


    Breast Cancer (Dove Med Press)

  29. KAST RE, Skuli N, Cos S, Karpel-Massler G, et al
    The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.
    Breast Cancer (Dove Med Press). 2017;9:495-514.
    >> Share

  30. LIANG Y, Goyette S, Hyder SM
    Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells.
    Breast Cancer (Dove Med Press). 2017;9:487-494.
    >> Share

  31. ARNABOLDI P, Riva S, Crico C, Pravettoni G, et al
    A systematic literature review exploring the prevalence of post-traumatic stress disorder and the role played by stress and traumatic stress in breast cancer diagnosis and trajectory.
    Breast Cancer (Dove Med Press). 2017;9:473-485.
    >> Share

  32. PIVA R, Ticconi F, Ceriani V, Scalorbi F, et al
    Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence.
    Breast Cancer (Dove Med Press). 2017;9:461-471.
    >> Share


    Breast Cancer Res

  33. TOOMEY S, Eustace AJ, Fay J, Sheehan KM, et al
    Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
    Breast Cancer Res. 2017;19:87.
    >> Share

  34. HUGO HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, et al
    Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Breast Cancer Res. 2017;19:86.
    >> Share

  35. SHAWON MSR, Eriksson M, Li J
    Body size in early life and risk of breast cancer.
    Breast Cancer Res. 2017;19:84.
    >> Share


    Breast Cancer Res Treat

  36. LIU H, Wang J, Zhang M, Xuan Q, et al
    Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.
    Breast Cancer Res Treat. 2017 Jul 20. doi: 10.1007/s10549-017-4394.
    >> Share

  37. SANTIAGO L, Adrada BE, Huang ML, Wei W, et al
    Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast.
    Breast Cancer Res Treat. 2017 Jul 20. doi: 10.1007/s10549-017-4401.
    >> Share

  38. HERTZ DL, Kidwell KM, Hilsenbeck SG, Oesterreich S, et al
    CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.
    Breast Cancer Res Treat. 2017 Jul 20. doi: 10.1007/s10549-017-4400.
    >> Share

  39. KWAPISZ D
    Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib.
    Breast Cancer Res Treat. 2017 Jul 24. doi: 10.1007/s10549-017-4385.
    >> Share

  40. SANTA-MARIA CA, Kruse M, Raska P, Weiss M, et al
    Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
    Breast Cancer Res Treat. 2017 Jul 27. doi: 10.1007/s10549-017-4415.
    >> Share

  41. ACCORDINO MK, Wright JD, Vasan S, Neugut AI, et al
    Association between survival time with metastatic breast cancer and aggressive end-of-life care.
    Breast Cancer Res Treat. 2017 Jul 27. doi: 10.1007/s10549-017-4420.
    >> Share

  42. WILSON FR, Varu A, Mitra D, Cameron C, et al
    Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Jul 27. doi: 10.1007/s10549-017-4404.
    >> Share

  43. LUITEN JD, Voogd AC, Luiten EJT, Duijm LEM, et al
    Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
    Breast Cancer Res Treat. 2017 Jul 26. doi: 10.1007/s10549-017-4412.
    >> Share

  44. WATT LF, Panicker N, Mannan A, Copeland B, et al
    Functional importance of PP2A regulatory subunit loss in breast cancer.
    Breast Cancer Res Treat. 2017 Jul 25. doi: 10.1007/s10549-017-4403.
    >> Share

  45. GROBMYER SR, Djohan R
    Comments on "Primary tumor location predicts the site of local relapse after nipple-areola complex (NAC) sparing mastectomy" by Cont et al. Breast Cancer Res Treat, 2017.
    Breast Cancer Res Treat. 2017 Jul 25. doi: 10.1007/s10549-017-4409.
    >> Share

  46. WU W, Chen J, Ye W, Li X, et al
    Fatty liver decreases the risk of liver metastasis in patients with breast cancer: a two-center cohort study.
    Breast Cancer Res Treat. 2017 Jul 24. doi: 10.1007/s10549-017-4411.
    >> Share

  47. SHI M, Ma F, Liu J, Xing H, et al
    A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy.
    Breast Cancer Res Treat. 2017 Jul 25. doi: 10.1007/s10549-017-4395.
    >> Share


    Breast J

  48. TANG HKC, Lee DYH, Thompson I, Ingram JR, et al
    Delayed and localized Sweets syndrome after breast cancer radiotherapy.
    Breast J. 2017 Jul 25. doi: 10.1111/tbj.12877.
    >> Share

  49. SUGRUE R, Carthy E, Kelly ME, Sweeney KJ, et al
    Science or popular media: What drives breast cancer online activity?
    Breast J. 2017 Jul 26. doi: 10.1111/tbj.12864.
    >> Share

  50. PAN K, Lin EM, Chlebowski RT
    Emerging combination endocrine therapies for advanced breast cancer.
    Breast J. 2017 Jul 26. doi: 10.1111/tbj.12876.
    >> Share


    Cancer Res

  51. FINLAY-SCHULTZ J, Gillen AE, Brechbuhl HM, Ivie JJ, et al
    Breast cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III.
    Cancer Res. 2017 Jul 20. pii: canres.3541.2016.
    >> Share


    Clin Breast Cancer

  52. FRATAMICO RS, Strickland KS, Uppal G, Abu-Khalaf M, et al
    A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia.
    Clin Breast Cancer. 2017 Jul 4. pii: S1526-8209(17)30092.
    >> Share

  53. YOKOYAMA S, Tamaru S, Tamaki S, Nakanishi D, et al
    Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy.
    Clin Breast Cancer. 2017 Jun 29. pii: S1526-8209(17)30142.
    >> Share

  54. IBRAHIM M, Muanza T, Smirnow N, Sateren W, et al
    A Pilot Randomized Controlled Trial on the Effects of a Progressive Exercise Program on the Range of Motion and Upper Extremity Grip Strength in Young Adults With Breast Cancer.
    Clin Breast Cancer. 2017 Jun 24. pii: S1526-8209(17)30032.
    >> Share

  55. COLLARINO A, de Koster EJ, Valdes Olmos RA, de Geus-Oei LF, et al
    Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
    Clin Breast Cancer. 2017 Jun 29. pii: S1526-8209(17)30059.
    >> Share


    Clin Cancer Res

  56. FORMISANO L, Stauffer KM, Young CD, Bhola NE, et al
    Association of FGFR1 with ERalphamaintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer.
    Clin Cancer Res. 2017 Jul 27. pii: clincanres.1232.2017.
    >> Share


    Eur J Cancer

  57. BARINOFF J, Schmidt M, Schneeweiss A, Schoenegg W, et al
    Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgery.
    Eur J Cancer. 2017;83:116-124.
    >> Share


    Eur J Surg Oncol

  58. THOMAS R, Pieri A, Cain H
    A systematic review of generic and breast cancer specific life expectancy models in the elderly.
    Eur J Surg Oncol. 2017 Jul 18. pii: S0748-7983(17)30575.
    >> Share


    Exp Cell Res

  59. TVEITARAS MK, Reigstad I, Leiss L, Reed RK, et al
    Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses.
    Exp Cell Res. 2017 Jul 19. pii: S0014-4827(17)30393.
    >> Share


    Gene

  60. BELYAVSKAYA VA, Prudnikova TY, Domanitskaya NV, Litviakov NV, et al
    GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.
    Gene. 2017 Jul 19. pii: S0378-1119(17)30578-4. doi: 10.1016/j.gene.2017.
    >> Share


    Int J Oncol

  61. WANG Y, Wang H, Ding Y, Li Y, et al
    N-peptide of vMIP- reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.
    Int J Oncol. 2017 Jul 19. doi: 10.3892/ijo.2017.4076.
    >> Share


    Int J Radiat Oncol Biol Phys

  62. GRELLIER ADEDJOUMA N, Chevrier M, Fourquet A, Costa E, et al
    Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After Mastectomy.
    Int J Radiat Oncol Biol Phys. 2017;98:206-214.
    >> Share

  63. PENNINKHOF J, Spadola S, Breedveld S, Baaijens M, et al
    Individualized Selection of Beam Angles and Treatment Isocenter in Tangential Breast Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:447-453.
    >> Share

  64. BAKKER A, Kolff MW, Holman R, van Leeuwen CM, et al
    Thermal Skin Damage During Reirradiation and Hyperthermia Is Time-Temperature Dependent.
    Int J Radiat Oncol Biol Phys. 2017;98:392-399.
    >> Share


    J Clin Oncol

  65. FREEDMAN RA, Keating NL, Pace LE, Lii J, et al
    Use of Surveillance Mammography Among Older Breast Cancer Survivors by Life Expectancy.
    J Clin Oncol. 2017 Jul 27:JCO2016721209. doi: 10.1200/JCO.2016.72.1209.
    >> Share


    Lancet Oncol

  66. DERKS MGM, Blok EJ, Seynaeve C, Nortier JWR, et al
    Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.
    Lancet Oncol. 2017 Jul 18. pii: S1470-2045(17)30419.
    >> Share


    Mod Pathol

  67. AGUILAR-MAHECHA A, Lafleur J, Pelmus M, Seguin C, et al
    The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience.
    Mod Pathol. 2017 Jul 28. doi: 10.1038/modpathol.2017.
    >> Share


    NPJ Breast Cancer

  68. O'FLANAGAN CH, Rossi EL, McDonell SB, Chen X, et al
    Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer.
    NPJ Breast Cancer. 2017;3:26.
    >> Share


    Oncol Rep

  69. FU X, Mao X, Wang Y, Ding X, et al
    Let-7c-5p inhibits cell proliferation and induces cell apoptosis by targeting ERCC6 in breast cancer.
    Oncol Rep. 2017 Jul 19. doi: 10.3892/or.2017.5839.
    >> Share

  70. MA SY, Park JH, Jung H, Ha SM, et al
    Snail maintains metastatic potential, cancer stem-like properties, and chemoresistance in mesenchymal mouse breast cancer TUBOP2J cells.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5834.
    >> Share


    PLoS One

  71. ABANA CO, Bingham BS, Cho JH, Graves AJ, et al
    IL-6 variant is associated with metastasis in breast cancer patients.
    PLoS One. 2017;12:e0181725.
    >> Share

  72. DONNELLY TT, Al-Khater AH, Al-Bader SB, Al-Kuwari MG, et al
    Perceptions of Arab men regarding female breast cancer screening examinations-Findings from a Middle East study.
    PLoS One. 2017;12:e0180696.
    >> Share


    Proc Natl Acad Sci U S A

  73. WRIGHT HJ, Hou J, Xu B, Cortez M, et al
    CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
    Proc Natl Acad Sci U S A. 2017 Jul 24. pii: 201703791.
    >> Share


    Radiology

  74. FUKADA I, Araki K, Kobayashi K, Shibayama T, et al
    Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer.
    Radiology. 2017 Jul 24:161548. doi: 10.1148/radiol.2017161548.
    >> Share


    Radiother Oncol

  75. ARSENE-HENRY A, Fourquet A, Kirova YM
    Evolution of radiation techniques in the treatment of breast cancer (BC) patients: From 3D conformal radiotherapy (3D CRT) to intensity-modulated RT (IMRT) using Helical Tomotherapy (HT): A single-centre experience.
    Radiother Oncol. 2017 Jul 18. pii: S0167-8140(17)32450.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016